Related Experiment Videos

Hemorrhagic cardiomyopathy and hemothorax in vitamin K deficient mice

A M Allen1, C T Hansen, T D Moore

  • 1Microbiological Associates, Inc., Rockville, Maryland 20850.

Toxicologic Pathology
|January 1, 1991
PubMed

Insights

Vitamin K deficiency caused a fatal condition in mice, leading to hemorrhagic cardiomyopathy and blood clotting issues. Supplementing vitamin K (menadione Na-bisulfite) resolved the outbreak, confirming the deficiency as the cause.

Area of Science:

  • Veterinary Pathology
  • Nutritional Science
  • Hematology

Background:

  • A fatal condition characterized by hemorrhagic cardiomyopathy, hemothorax, and coagulation defects was observed in hysterectomy-derived male mice.
  • Microscopic examination revealed multifocal hemorrhage, necrosis, inflammation, and fibroplasia in the heart, particularly near the atrioventricular junction.

Purpose of the Study:

  • To investigate the etiology of the fatal hemorrhagic condition in mice.
  • To determine the role of vitamin K in the observed syndrome.

Main Methods:

  • Investigated a spontaneous outbreak in mice.
  • Administered a vitamin K-free diet to germ-free male mice.
  • Administered Warfarin to conventional male and female mice.
  • Assessed the effects of menadione Na-bisulfite (vitamin K) supplementation.

Main Results:

  • The outbreak was halted by increasing dietary menadione Na-bisulfite (vitamin K) to 20 ppm.
  • The syndrome, including hemorrhagic cardiomyopathy, was reproducible in mice on a vitamin K-free diet.
  • Warfarin administration also induced the syndrome in conventional mice.

Conclusions:

  • The primary cause of the observed fatal condition, including hemorrhagic cardiomyopathy and coagulation defects, was identified as vitamin K deficiency.
  • Dietary vitamin K levels are critical for preventing this syndrome in mice.

Related Concept Videos